Clinical trial
Study of the Impact of Air Versus SF6 20% on Visual Acuity Improvement After Epiretinal Membrane Stripping
NCT02030262 is registered in ClinicalTrials.gov with CHU de Quebec-Universite Laval as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of the Impact of Air Versus SF6 20% on Visual Acuity Improvement After Epiretinal Membrane Stripping
- Lead sponsor
- CHU de Quebec-Universite Laval
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 31, 2013
- Completion date
- February 29, 2016
- Enrollment
- 32 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.